In order to avoid the influence of hormones on tumor expression, combined with clinical information, we divided the patients into two groups of pre- and post-menopausal women, and compared the expression of IFITM1, CD10, h-caldesmon, and SMA in EST and CL between pre- and post-menopausal women (Table 6). The gene discussed is IFITM1; the disease is neoplasm.